Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance

Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance

Abstract Background A post-marketing surveillance of blonanserin has been ongoing since September 2018. The aim of this study was to assess the effectiveness and safety of oral blonanserin in Chinese young and middle-aged female patients with schizophrenia in real clinical settings, using the data f...

Full description

Bibliographic Details
Main Authors: Qijing Bo, Xijin Wang, Xuejun Liu, Hong Sang, Zhiyuan Xun, Ruiling Zhang, Xiaodong Yang, Huaili Deng, Keqing Li, Jindong Chen, Meijuan Sun, Guijun Zhao, Xianglai Liu, Duanfang Cai, Guilai Zhan, Juhong Li, Haiyun Li, Gang Wang
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Psychiatry
Subjects:
Blonanserin
Effectiveness
Safety
Women
Schizophrenia
Online Access:https://doi.org/10.1186/s12888-023-04598-y

Internet

https://doi.org/10.1186/s12888-023-04598-y

Similar Items